MARC Record from Library of Congress

LEADER: 02116cam a22003974a 4500
001 2010022384
003 DLC
005 20110707084102.0
008 100526s2010 njuaf b 001 0 eng
010 $a 2010022384
016 7 $a101546647$2DNLM
020 $a9780470286241 (hardback)
020 $a0470286245 (hardback)
035 $a(OCoLC)ocn466334055
040 $aDLC$cDLC$dBTCTA$dYDXCP$dC#P$dBWX$dCDX$dILU$dNLM$dDLC
042 $apcc
050 00 $aTP248.65.E59$bE59144 2010
060 00 $a2010 L-385
060 10 $aQU 135
082 00 $a660.6/34$222
245 00 $aEnzyme technologies :$bmetagenomics, evolution, biocatalysis, and biosynthesis /$cedited by Wu-Kuang Yeh, Hsiu-Chiung Yang, James R. McCarthy.
260 $aHoboken, N.J. :$bWiley,$cc2010.
300 $axi, 368 p., [8] p. of plates :$bill. (some col.) ;$c25 cm.
490 1 $aChemical biology of enzymes for biotechnology and pharmaceutical applications ;$vv. 1
504 $aIncludes bibliographical references and index.
520 $a"Enzyme Technologies in Drug Discovery highlights how, what, and where enzymes have become critical in pharmaceutical and biotechnology research. This book provides in-depth reviews of recent developments in biosynthesis, biocatalysis, and the chemical biology of enzymes. This text discusses enzymatic assays, including emerging assay technologies for key enzyme classes in pharmaceutical research. In addition to new developments in proteomics, this book includes two emerging technologies in life sciences, metabolomics and preclinomics. This volume reviews important progress on the chemical biology of enzymes in the post-genomic era"--$cProvided by publisher.
650 0 $aEnzymes$xBiotechnology.
650 0 $aPharmaceutical biotechnology.
650 12 $aEnzymes$xmetabolism.
650 22 $aDrug Discovery.
650 22 $aEnzymes$xbiosynthesis.
650 22 $aMetagenomics$xmethods.
700 1 $aYeh, Wu-Kuang,$d1942-
700 1 $aYang, Hsiu-Chiung.
700 1 $aMcCarthy, James R.,$d1943-
830 0 $aChemical biology of enzymes for biotechnology and pharmaceutical applications ;$vv. 1.